BackMEDIROM Healthcare Technologies Overview

MEDIROM Healthcare Technologies Net Income

Latest net income for MRM: $210M, below the Consumer Discretionary sector average of $140B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

$63.43M
91.32% YoY

As of Dec 2025

Annual Net Income (TTM)

$207.54M
13969.8% YoY

Trailing 12 months ending Dec 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

MEDIROM Healthcare Technologies (MRM) FAQ

The latest net income for MRM is $210M as of December 2025. That compares with $1.5M in the prior-year period — up 13969.8% year over year. That is below the Consumer Discretionary sector average of $140B. Investors often review this figure alongside MEDIROM Healthcare Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, MRM's net income moved from $1.5M to $210M — a 13969.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MEDIROM Healthcare Technologies's operating scale or balance-sheet position.

Against Consumer Discretionary companies, MRM currently prints $210M for net income, while the sector average sits near $140B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at MEDIROM Healthcare Technologies's growth, margins, and balance sheet.

A net income figure of $210M for MRM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Discretionary average is about $140B. Explore the charts below for those layers of context.

After noting MRM's net income ($210M), review year-over-year change from $1.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.